Application | Comment | Organism |
---|---|---|
medicine | the human multidrug resistance transporter P-glycoprotein (P-gp) prevents the entry of compounds into the brain by an active efflux mechanism at the blood-brain barrier. In treatment of neurodegenerative diseases the development of new reversible inhibitors of P-gp is pertinent to overcome this problem. Design and synthesis of a crosslinked agent based on the Alzheimers disease treatment galantamine (Gal-2, bis[(4aS,6R,8aS)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-yl] decanedioate) that inhibits P-gp-mediated efflux from cultured cells. Gal-2 inhibits the efflux of the fluorescent P-gp substrate rhodamine 123 in cancer cells that over-express P-gp. It inhibits the efflux of therapeutic substrates of P-gp, such as doxorubicin, daunomycin and verapamil. Potential role of Gal-2, as inhibitors of P-gp at the blood-brain barrier to augment treatment of neurodegenerative diseases | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expression in Sf9 cells | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
bis[(4aS,6R,8aS)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-yl] decanedioate | galactamine dimer. the inhibitory activity of the inhibitor on P-gp transport of substrate is evaluated in cells that over-express P-gp | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | the human multidrug resistance transporter P-glycoprotein prevents the entry of compounds into the brain by an active efflux mechanism at the blood-brain barrier | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + H2O + daunomycin/in | - |
Homo sapiens | ADP + phosphate + daunomycin/out | - |
? | |
ATP + H2O + doxorubicin/in | - |
Homo sapiens | ADP + phosphate + doxorubicin/out | - |
? | |
ATP + H2O + rhodamine 123/in | - |
Homo sapiens | ADP + phosphate + rhodamine 123/out | - |
? | |
ATP + H2O + verapamil/in | - |
Homo sapiens | ADP + phosphate + verapamil/out | - |
? | |
additional information | the human multidrug resistance transporter P-glycoprotein prevents the entry of compounds into the brain by an active efflux mechanism at the blood-brain barrier | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
P-glycoprotein | - |
Homo sapiens |
P-gp | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0003 | - |
22°C, pH 7.4, inhibition of verapamil efflux in MCF-7/DX1 (breast adenocarcinoma) cells that over-express P-gp | Homo sapiens | bis[(4aS,6R,8aS)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-yl] decanedioate | |
0.0005 | - |
22°C, pH 7.4, inhibition of doxorubicin efflux in MCF-7/DX1 (breast adenocarcinoma) cells that over-express P-gp | Homo sapiens | bis[(4aS,6R,8aS)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-yl] decanedioate | |
0.0006 | - |
22°C, pH 7.4, inhibition of rhodamine 123 efflux in MCF-7/DX1 (breast adenocarcinoma) cells that over-express P-gp | Homo sapiens | bis[(4aS,6R,8aS)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-yl] decanedioate | |
0.0016 | - |
22°C, pH 7.4, inhibition of daunomycin efflux in MCF-7/DX1 (breast adenocarcinoma) cells that over-express P-gp | Homo sapiens | bis[(4aS,6R,8aS)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-yl] decanedioate |
General Information | Comment | Organism |
---|---|---|
physiological function | the human multidrug resistance transporter P-glycoprotein prevents the entry of compounds into the brain by an active efflux mechanism at the blood-brain barrier | Homo sapiens |